These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20859895)

  • 1. [Lights and shadows using ICD therapy].
    Kutarski A
    Kardiol Pol; 2010 Sep; 68(9):1030-1. PubMed ID: 20859895
    [No Abstract]   [Full Text] [Related]  

  • 2. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients.
    Sterliński M; Przybylski A; Gepner K; Syska P; Maciag A; Lewandowski M; Kowalik I; Pytkowski M; Sitkowska-Rysiak E; Lichomski J; Szwed H; Sadowski Z
    Kardiol Pol; 2010 Sep; 68(9):1023-9. PubMed ID: 20859894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrical storm in patients with implantable cardioverter-defibrillator].
    Mitręga K; Średniawa B; Kowalski O; Lenarczyk R; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2013; 71(2):198-201; discussion 202. PubMed ID: 23575717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.
    Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H
    Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 8. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 9. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
    Andresen D
    Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
    Huikuri HV
    Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
    [No Abstract]   [Full Text] [Related]  

  • 12. Inappropriate sensing in a single-chamber ICD--what is the mechanism?
    Seegers J; Zabel M; Sweeney MO; Vollmann D
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1699-703. PubMed ID: 21501178
    [No Abstract]   [Full Text] [Related]  

  • 13. Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?
    Ray IB; Reddy VY
    Int J Cardiol; 2005 Jan; 98(1):15-20. PubMed ID: 15676160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting and preventing sudden cardiac death.
    Estes NA
    Circulation; 2011 Aug; 124(5):651-6. PubMed ID: 21810674
    [No Abstract]   [Full Text] [Related]  

  • 15. [The implantable cardioverter-defibrillator: sometimes necessary].
    Smeets JL
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2113-5. PubMed ID: 15553353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
    Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
    Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twisting until it breaks: a rare cause of ICD lead failure.
    Budzikowski AS; Uyguanco E; Gunsburg MY; Kassotis J
    Cardiol J; 2008; 15(6):558-60. PubMed ID: 19039762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICD therapy in coronary artery disease. A reappraisal in 2005.
    Grönefeld G; Manegold J; Israel CW; Hohnloser SH
    Herz; 2005 Mar; 30(2):82-6. PubMed ID: 15875095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.